LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,691,852 | +17.4% | 43,815 | +1.8% | 0.00% | 0.0% |
| Q1 2024 | $3,146,005 | +2.4% | 43,037 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $3,073,702 | +20.2% | 43,037 | +0.9% | 0.00% | 0.0% |
| Q3 2023 | $2,556,487 | -58.3% | 42,665 | -49.8% | 0.00% | -50.0% |
| Q2 2023 | $6,126,986 | +128780.6% | 84,979 | +31.5% | 0.00% | 0.0% |
| Q1 2023 | $4,754 | +58.2% | 64,630 | +43.6% | 0.00% | +100.0% |
| Q4 2022 | $3,006 | -99.9% | 44,994 | -13.3% | 0.00% | -50.0% |
| Q3 2022 | $4,469,000 | -6.1% | 51,898 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $4,757,000 | -22.1% | 53,320 | -1.6% | 0.00% | 0.0% |
| Q1 2022 | $6,109,000 | -20.8% | 54,168 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $7,709,000 | -10.7% | 55,445 | -7.1% | 0.00% | -33.3% |
| Q3 2021 | $8,637,000 | -30.6% | 59,677 | -37.1% | 0.00% | -25.0% |
| Q2 2021 | $12,445,000 | -15.7% | 94,871 | -2.1% | 0.00% | -20.0% |
| Q1 2021 | $14,767,000 | +114.8% | 96,863 | +40.1% | 0.01% | +150.0% |
| Q4 2020 | $6,876,000 | +1.4% | 69,137 | -2.8% | 0.00% | -33.3% |
| Q3 2020 | $6,782,000 | -17.6% | 71,158 | -3.4% | 0.00% | 0.0% |
| Q2 2020 | $8,235,000 | -4.4% | 73,629 | -37.8% | 0.00% | -25.0% |
| Q1 2020 | $8,610,000 | -24.8% | 118,395 | +7.9% | 0.00% | 0.0% |
| Q4 2019 | $11,443,000 | +0.6% | 109,715 | -4.0% | 0.00% | -20.0% |
| Q3 2019 | $11,378,000 | -13.0% | 114,309 | -0.3% | 0.01% | 0.0% |
| Q2 2019 | $13,081,000 | +776.7% | 114,596 | +942.3% | 0.01% | -44.4% |
| Q4 2018 | $1,492,000 | -52.6% | 10,995 | -4.2% | 0.01% | -47.1% |
| Q3 2018 | $3,151,000 | +26.4% | 11,478 | -4.6% | 0.02% | +6.2% |
| Q2 2018 | $2,492,000 | +46.5% | 12,028 | +16.8% | 0.02% | +45.5% |
| Q1 2018 | $1,701,000 | +34.3% | 10,302 | +11.4% | 0.01% | +37.5% |
| Q4 2017 | $1,267,000 | -1.9% | 9,251 | -2.5% | 0.01% | 0.0% |
| Q3 2017 | $1,292,000 | +70.7% | 9,492 | +52.2% | 0.01% | +60.0% |
| Q2 2017 | $757,000 | -0.8% | 6,236 | -13.4% | 0.01% | 0.0% |
| Q1 2017 | $763,000 | – | 7,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
| OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
| Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
| ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
| First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
| Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
| OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
| RK Capital | 127,983 | $13,876,000 | 2.42% |
| Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |